The genomic and epigenomic landscape in thymic carcinoma

about

Identification of a novel therapeutic target in driver-negative non-small cell lung cancer

P2860

Q58562470-5559535B-0AE1-4563-A482-B066DA43D85D

P2860

The genomic and epigenomic landscape in thymic carcinoma

Item

http://www.wikidata.org/entity/Q57700809

description

im September 2017 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 October 2017

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2017

@uk

name

The genomic and epigenomic landscape in thymic carcinoma

@en

The genomic and epigenomic landscape in thymic carcinoma

@nl

type

Item

label

The genomic and epigenomic landscape in thymic carcinoma

@en

The genomic and epigenomic landscape in thymic carcinoma

@nl

prefLabel

The genomic and epigenomic landscape in thymic carcinoma

@en

The genomic and epigenomic landscape in thymic carcinoma

@nl

P1476

The genomic and epigenomic landscape in thymic carcinoma

@en

P2093

Koji Kono

http://www.w3.org/2001/XMLSchema#string

Koji Tsuta

http://www.w3.org/2001/XMLSchema#string

Shunichi Watanabe

http://www.w3.org/2001/XMLSchema#string

Takashi Kohno

http://www.w3.org/2001/XMLSchema#string

Takayuki Honda

http://www.w3.org/2001/XMLSchema#string

Yae Kanai

http://www.w3.org/2001/XMLSchema#string

Yoko Shimada

http://www.w3.org/2001/XMLSchema#string

Yuichiro Ohe

http://www.w3.org/2001/XMLSchema#string

P2860

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts

Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.

Mutational landscape and significance across 12 major cancer types

Signatures of mutational processes in human cancer

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease

GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution

P304

1084-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGX094

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tetsuhiko Asao

Motonobu Saito

Yutaka Fujiwara

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968686

http://www.w3.org/2001/XMLSchema#string

The genomic and epigenomic landscape in thymic carcinoma

about

P2860

P2860

The genomic and epigenomic landscape in thymic carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698